Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Primeva: Lopinavir/Ritonavir for Prevention of HIV-1 Mother-to-Child Transmission
NCT00424814Phase 3Completed
- Sponsor
- ANRS
- Start
- Mar 2007
- Primary completion
- Sep 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of lopinavir + ritonavir in human immunodeficiency virus infection (HIV), sponsored by ANRS. Started Mar 2007; status: completed.
02
Drugs
lopinavir + ritonavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00424814.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00424814.